Pfizer Q3 net profit up 40 percent at Rs 87 crore
New Delhi: Drug firm Pfizer reported a 39.87 percent rise in its net profit at Rs 87.24 crore for the quarter ended December 2017, mainly on account of lower expenses.
The company had posted a net profit of Rs 62.37 crore during the same period of the previous fiscal, Pfizer said in a regulatory filing.
Revenue from operations for the quarter under review stood at Rs 456.5 crore as compared to Rs 510.2 crore in the same period of the last year.
It said net profit after tax (including other comprehensive income) for nine months ended December 31, 2017, was Rs 254.9 crore as against Rs 267.6 crore in the year-ago period.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd